Using the MCF10A/MCF10CA1a Breast Cancer Progression Cell Line Model to Investigate the Effect of Active, Mutant Forms of EGFR in Breast Cancer Development and Treatment Using Gefitinib

BACKGROUND: Basal-like and triple negative breast cancer (TNBC) share common molecular features, poor prognosis and a propensity for metastasis to the brain. Amplification of epidermal growth factor receptor (EGFR) occurs in ~50% of basal-like breast cancer, and mutations in the epidermal growth fac...

Descripción completa

Detalles Bibliográficos
Autores principales: Bessette, Darrell C., Tilch, Erik, Seidens, Tatjana, Quinn, Michael C. J., Wiegmans, Adrian P., Shi, Wei, Cocciardi, Sibylle, McCart-Reed, Amy, Saunus, Jodi M., Simpson, Peter T., Grimmond, Sean M., Lakhani, Sunil R., Khanna, Kum Kum, Waddell, Nic, Al-Ejeh, Fares, Chenevix-Trench, Georgia
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2015
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4430383/
https://www.ncbi.nlm.nih.gov/pubmed/25969993
http://dx.doi.org/10.1371/journal.pone.0125232

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4430383/
https://www.ncbi.nlm.nih.gov/pubmed/25969993
http://dx.doi.org/10.1371/journal.pone.0125232

Ejemplares similares